作者:L. A. Fonina、A. A. Az’muko、V. N. Kalikhevich、M. L. Lewit、Z. A. Ardemasova、S. A. Gur’yanov、R. G. Belevskaya、M. A. Efremov、E. M. Treshchalina、A. A. Mikhailova
DOI:10.1134/s106816200804002x
日期:2008.7
The Val-Val-Tyr-Pro-Asp bone marrow peptide (MP-5) and its analogue (MP-5-Lys) were synthesized. Fluorescent derivatives, Ftc-MP-5 and MP-5-Lys(Ftc), were prepared. The iological activity of MP-5 and MP-5-Lys was studied in vitro and in vivo. The MP-5 peptide caused 60-84% inhibition of growth of the following mouse cancers: lymphatic leukemia P388, melanoma B-16, and cervical carcinoma CUC-5. These peptides also restored functional activity of T-lymphocytes that was inhibited by metabolic products of the HL-60 leukemic cell line. MP-5-Lys(Ftc) was shown to preserve the functional properties of MP-5 towards T-lymphocytes, but Ftc-MP-5 was practically inactive.